SK862002A3 - Catalytic anti-factor viii allo-antibodies - Google Patents

Catalytic anti-factor viii allo-antibodies Download PDF

Info

Publication number
SK862002A3
SK862002A3 SK86-2002A SK862002A SK862002A3 SK 862002 A3 SK862002 A3 SK 862002A3 SK 862002 A SK862002 A SK 862002A SK 862002 A3 SK862002 A3 SK 862002A3
Authority
SK
Slovakia
Prior art keywords
factor viii
antibodies
allo
inhibitor
asp
Prior art date
Application number
SK86-2002A
Other languages
English (en)
Slovak (sk)
Inventor
Srinivas Kaveri
Sebastien Lacroix-Desmazes
Michel Kazatchkine
Original Assignee
Inst Nat Sante Rech Med
Bayer Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Nat Sante Rech Med, Bayer Pharma filed Critical Inst Nat Sante Rech Med
Publication of SK862002A3 publication Critical patent/SK862002A3/sk

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
SK86-2002A 1999-07-21 2000-07-18 Catalytic anti-factor viii allo-antibodies SK862002A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP99401841A EP1074842A1 (en) 1999-07-21 1999-07-21 Catalytic anti-factor VIII allo-antibodies
PCT/EP2000/006870 WO2001007918A1 (en) 1999-07-21 2000-07-18 Catalytic anti-factor viii allo-antibodies

Publications (1)

Publication Number Publication Date
SK862002A3 true SK862002A3 (en) 2002-06-04

Family

ID=8242069

Family Applications (1)

Application Number Title Priority Date Filing Date
SK86-2002A SK862002A3 (en) 1999-07-21 2000-07-18 Catalytic anti-factor viii allo-antibodies

Country Status (24)

Country Link
US (2) US7507540B1 (ja)
EP (2) EP1074842A1 (ja)
JP (2) JP2003505434A (ja)
KR (1) KR100788435B1 (ja)
CN (1) CN1229646C (ja)
AU (1) AU777615B2 (ja)
BR (1) BR0012613A (ja)
CA (1) CA2379818A1 (ja)
CZ (1) CZ2002248A3 (ja)
EE (1) EE200200034A (ja)
HK (1) HK1044372A1 (ja)
HU (1) HUP0201941A3 (ja)
IL (1) IL147700A0 (ja)
IS (1) IS6238A (ja)
MX (1) MXPA02000752A (ja)
NO (1) NO20020253L (ja)
NZ (1) NZ516702A (ja)
PL (1) PL353739A1 (ja)
RU (1) RU2258935C2 (ja)
SK (1) SK862002A3 (ja)
TR (1) TR200200340T2 (ja)
UA (1) UA75867C2 (ja)
WO (1) WO2001007918A1 (ja)
ZA (1) ZA200200351B (ja)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT2644698T (pt) 2010-11-17 2018-01-31 Chugai Pharmaceutical Co Ltd Molécula multiespecífica de ligação ao antigénio com uma função alternativa à função do fator viii de coagulação do sangue
FR2969761A1 (fr) * 2010-12-22 2012-06-29 Lfb Biotechnologies Procede de dosage d'anticorps diriges contre le facteur viii
TWI701435B (zh) * 2014-09-26 2020-08-11 日商中外製藥股份有限公司 測定ｆｖｉｉｉ的反應性之方法
TWI700300B (zh) 2014-09-26 2020-08-01 日商中外製藥股份有限公司 中和具有第ｖｉｉｉ凝血因子（ｆｖｉｉｉ）機能替代活性的物質之抗體

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5744446A (en) * 1992-04-07 1998-04-28 Emory University Hybrid human/animal factor VIII
AU5602394A (en) * 1992-11-13 1994-06-08 Duke University Chimeric blood coagulation proteins
US5910481A (en) * 1995-11-13 1999-06-08 Immuno Ag Hybrid proteins with modified activity
US5744326A (en) * 1996-03-11 1998-04-28 The Immune Response Corporation Use of viral CIS-acting post-transcriptional regulatory sequences to increase expression of intronless genes containing near-consensus splice sites

Also Published As

Publication number Publication date
US20090208512A1 (en) 2009-08-20
RU2258935C2 (ru) 2005-08-20
KR20020042618A (ko) 2002-06-05
EE200200034A (et) 2003-06-16
NO20020253L (no) 2002-03-13
AU777615B2 (en) 2004-10-21
CN1229646C (zh) 2005-11-30
HUP0201941A2 (en) 2002-10-28
HK1044372A1 (zh) 2002-10-18
CZ2002248A3 (cs) 2002-07-17
EP1196782A1 (en) 2002-04-17
US7507540B1 (en) 2009-03-24
IS6238A (is) 2002-01-16
WO2001007918A1 (en) 2001-02-01
NO20020253D0 (no) 2002-01-17
IL147700A0 (en) 2002-08-14
CA2379818A1 (en) 2001-02-01
HUP0201941A3 (en) 2005-01-28
BR0012613A (pt) 2002-04-09
JP2009292823A (ja) 2009-12-17
CN1361865A (zh) 2002-07-31
PL353739A1 (en) 2003-12-01
UA75867C2 (en) 2006-06-15
JP2003505434A (ja) 2003-02-12
KR100788435B1 (ko) 2007-12-24
AU6824500A (en) 2001-02-13
TR200200340T2 (tr) 2003-01-21
NZ516702A (en) 2003-10-31
EP1074842A1 (en) 2001-02-07
MXPA02000752A (es) 2003-07-14
ZA200200351B (en) 2003-03-26

Similar Documents

Publication Publication Date Title
Mazurier et al. A new von Willebrand factor (vWF) defect in a patient with factor VIII (FVIII) deficiency but with normal levels and multimeric patterns of both plasma and platelet vWF. Characterization of abnormal vWF/FVIII interaction
EP0756638B1 (en) Means for treating disorders in the blood coagulation cascade
US20070212743A1 (en) Assays for Determining Anticoagulant Cofactor Activity
UA75064C2 (en) Modified porcine factor viii and its therapeutic use
JPH10500282A (ja) ハイブリッドヒト／動物第ｖｉｉｉ因子
AU2012299524A1 (en) Compounds for use in boosting coagulation
JPH11507542A (ja) プロトロンビン誘導体
US20090298779A1 (en) Peptides which Modulate Blood Coagulation and Methods of Use Thereof
US20090208512A1 (en) Catalytic anti-factor VIII allo-antibodies
CZ334095A3 (en) Compounds containing chains of amino acids, their use and pharmaceutical compositions containing thereof
Scicli et al. Relationship between structure and correcting activity of bovine high molecular weight kininogen upon the clotting time of Fitzgerald-trait plasma
JPH11507664A (ja) 第ｖｉｉｉ因子由来の第ｉｘ因子結合ペプチド及び血液凝固のインヒビターとしてのそれらの使用
US20030143759A1 (en) Assays for determining anticoagulant cofactor activity
WO2001098782A1 (fr) Kit de determination du pouvoir de coagulation du sang
Waldmann et al. The Role of High Molecular Weight Kininogen (Fitzgerald Factor) in the Activation of Various Plasma Proteolytic Enzyme Systems
Drohan et al. Recombinant Technology in Hemostasis and Thrombosis
Ramasamy INHERITED RISK FACTORS FOR VENOUS
McIntosh Investigations of the thrombin generation test for the measurement of factor VIII
PL181638B1 (pl) Sposób oznaczania sklonnosci do rozwoju zakrzepicy PL

Legal Events

Date Code Title Description
FB9A Suspension of patent application procedure